Global Cardiac Mapping Market Size, Share, Forecast Report, 2020-2027

The global cardiac mapping market size is expected to grow from USD 1.4 billion in 2019 to USD 2.1 billion by 2024, at a CAGR of 8.7% during the forecast period. Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.
The contact cardiac mapping segment is projected to grow at the highest rate during the forecast period
By product, the cardiac mapping market is segmented into contact cardiac mapping (electroanatomical mapping, basket catheter mapping, traditional endocardial mapping) and non-contact cardiac mapping. The contact cardiac mapping segment is expected to witness the fastest growth during the forecast period. Advantages offered by contact cardiac mapping, such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment, also with multi-electrode basket catheter, recording just a few beats might be enough to uncover the arrhythmia circuit; these factors are increasing its adoption. Consequently, the demand for cardiac mapping devices for diagnosing complex arrhythmias is also growing.

Atrial fibrillation held the largest share of the cardiac mapping systems market in 2019
Cardiac mapping is used widely for the identification, characterization, and localization of an arrhythmia. The cardiac mapping systems indication market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment held the largest share of the market in 2019, a trend that is expected to continue during the forecast period. The large share of this segment can primarily be attributed to the rising incidences of AF throughout the globe.
North America is expected to hold a dominant share in the cardiac mapping market during the forecast period
North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period. Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.

Key Market Players
The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence. The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).

This research report categorizes the cardiac mapping market based on product, indication, and region.

Based on Product:

• Contact Cardiac mapping systems
  • Electroanatomical mapping
  • Basket catheter mapping
  • Traditional endocardial catheter mapping
• Non-contact Cardiac mapping systems

Based on Indication:

• Atrial Fibrillation
• Atrial Flutter
• AVNRT
• Other Arrhythmias

Based on Region:

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC
• Rest of the World